Synapsin Pharmaceuticals, Inc.

United States of America

Back to Profile
1-5 of 5 for Synapsin Pharmaceuticals, Inc. Sort by
Query
Aggregations
Jurisdiction
        United States 3
        Canada 1
        World 1
IPC Class
A61K 31/445 - Non-condensed piperidines, e.g. piperocaine 5
A61K 35/64 - Insects, e.g. bees, wasps or fleas 2
C07D 211/12 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with only hydrogen atoms attached to the ring nitrogen atom 2
A61K 35/63 - Arthropods 1
A61P 25/28 - Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia 1
Found results for  patents

1.

Compositions and methods relating to solenopsins and their uses in treating neurological disorders and enhancing physical performance

      
Application Number 15005440
Grant Number 09943554
Status In Force
Filing Date 2016-01-25
First Publication Date 2016-11-03
Grant Date 2018-04-17
Owner SYNAPSIN PHARMACEUTICALS, INC. (USA)
Inventor
  • Dorsey, Denis
  • Kindy, Mark S.

Abstract

Provided herein are piperidine alkaloids and uses thereof in neurological disorders and physical enhancement applications.

IPC Classes  ?

  • A61K 35/64 - Insects, e.g. bees, wasps or fleas
  • A61K 31/445 - Non-condensed piperidines, e.g. piperocaine
  • C07D 211/12 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with only hydrogen atoms attached to the ring nitrogen atom
  • A61K 35/63 - Arthropods

2.

Compositions and methods relating to solenopsins and their uses in treating neurological disorders and enhancing physical performance

      
Application Number 13968049
Grant Number 09259419
Status In Force
Filing Date 2013-08-15
First Publication Date 2014-03-27
Grant Date 2016-02-16
Owner SYNAPSIN PHARMACEUTICALS, INC. (USA)
Inventor
  • Dorsey, Denis
  • Kindy, Mark S.

Abstract

Provided herein are piperidine alkaloids and uses thereof in neurological disorders and physical enhancement applications.

IPC Classes  ?

  • A61K 31/445 - Non-condensed piperidines, e.g. piperocaine
  • C07D 211/12 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with only hydrogen atoms attached to the ring nitrogen atom
  • A61K 35/64 - Insects, e.g. bees, wasps or fleas

3.

Compositions and methods relating to solenopsins and their uses in treating neurological disorders and enhancing cognitive and physical performance

      
Application Number 12307459
Grant Number 08524741
Status In Force
Filing Date 2007-07-09
First Publication Date 2010-03-04
Grant Date 2013-09-03
Owner Synapsin Pharmaceuticals, Inc. (USA)
Inventor
  • Dorsey, Denis
  • Kindy, Mark S.

Abstract

Provided herein are piperidine alkaloids and uses thereof in neurological disorders and physical enhancement applications.

IPC Classes  ?

  • A61K 31/445 - Non-condensed piperidines, e.g. piperocaine

4.

COMPOSITIONS AND METHODS RELATING TO SOLENOPSINS AND THEIR USES IN TREATING NEUROLOGICAL DISORDERS AND ENHANCING COGNITIVE AND PHYSICAL PERFORMANCE

      
Document Number 02657256
Status In Force
Filing Date 2007-07-09
Open to Public Date 2008-01-17
Grant Date 2015-04-07
Owner SYNAPSIN PHARMACEUTICALS, INC. (USA)
Inventor
  • Dorsey, Denis
  • Kindy, Mark S.

Abstract

Provided herein are piperidine alkaloids and uses thereof in neurological disorders and physical enhancement applications.

IPC Classes  ?

  • A61K 31/445 - Non-condensed piperidines, e.g. piperocaine
  • A61P 25/28 - Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

5.

COMPOSITIONS AND METHODS RELATING TO SOLENOPSINS AND THEIR USES IN TREATING NEUROLOGICAL DISORDERS AND ENHANCING PHYSICAL PERFORMANCE

      
Application Number US2007073018
Publication Number 2008/008720
Status In Force
Filing Date 2007-07-09
Publication Date 2008-01-17
Owner SYNAPSIN PHARMACEUTICALS, INC. (USA)
Inventor
  • Dorsey, Denis
  • Kindy, Mark, S.

Abstract

Provided herein are piperidine alkaloids and uses thereof in neurological disorders and physical enhancement applications.

IPC Classes  ?

  • A61K 31/445 - Non-condensed piperidines, e.g. piperocaine